Trade ALVO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alvotech (ALVO) is trading at US$4.29, down 5.71% today as of Nov 19, 16:00 EST. The company has a market capitalisation of US$1.56B. Over the past 52 weeks, ALVO has traded between US$2.94 and US$6.53. On Syfe you can trade ALVO with $0 commission and add it to your watchlist.
| Previous close | US$4.55 |
|---|---|
| Market cap | US$1.56B |
| P/E ratio | 20.63 |
| 52-week range | US$2.94 – US$6.53 |
| Volume | 676.56K |
| Exchange | US |
Alvotech
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
Year: 2022
Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS Says
Oct 20, 4:11 PM · MT Newswires
Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday
Oct 20, 1:20 PM · MT Newswires
Alvotech (ALVO) stock is trading at US$4.29, -5.71% from the previous close of US$4.55.
The market cap for Alvotech (ALVO) stock is approximately US$1.56B.
The price-to-earnings ratio for Alvotech (ALVO) is 20.63, based on the latest reported earnings.
The 52-week high for Alvotech (ALVO) stock is US$6.53.
The 52-week low for Alvotech (ALVO) stock is US$2.94.
Alvotech (ALVO) does not currently pay a dividend.
Stay on top of ALVO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore